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Background: It is widely acknowledged that suicidal behavior (SB) has a genetic influence. As a consequence,
molecular genetic studies have been mostly conducted on serotonergic genes. One of the most promising
candidate genes of this system is tryptophan hydroxylase (TPH). Although there have been several positive studies
associating TPH genes and SB, the evidence is not entirely consistent. Therefore, we performed a meta-analysis to
gain a better understanding into this issue.
Methods: The meta-analysis was conducted with 37 articles of genetic association studies of TPH-1 (A218C and
A779C) and TPH2 (G-703 T, A-473 T and G19918A) genes. To analyze the association of these variants with SB we
used the following models: allelic, additive, dominant and recessive. In addition, we performed a sub-group analysis
by Caucasian and Asian populations using the same four models.
Results: TPH-1 gene variants showed a positive significant association with SB, but only in the fixed effects models.
With regard to TPH-2 gene variants we could not find an association with SB.
Conclusions: The study provides evidence that A218C/A779C TPH-1 variants may be a risk factor to manifest SB at
the clinical level, which is in agreement with previously reported meta-analyses. With regard to G-703 T/A-473
T/G19918A TPH-2 variants, our up-to-date meta-analysis could not detect any significant association between those
genetic variants and SB. However, these results should be interpreted with caution since further studies need to be
undertaken using larger sample sizes in different ethnic populations to confirm our findings.
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Suicidal behavior (SB) is a leading cause of injury and
death worldwide; it accounts for almost one million
deaths annually and is the leading cause of death among
individuals between 15 and 44 years of age [1-3]. Suicide
has been defined as the act of intentionally ending one’s
own life. Nonfatal suicidal thoughts and behaviors are
classified more specifically into three categories: suicide
ideation (refers to thoughts and plans for ending one’s life),
suicide attempt (engagement in potentially self-injurious
behavior with no lethal outcome) and completed suicide
(the person ends with his/her life). There are several* Correspondence: alfonso_tovillaz@yahoo.com.mx
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article, unless otherwise stated.measurements of past suicidal behavior, which basically
consist in predicting future suicidal behavior, as well as to
obtain information about history ideation, plans and/or at-
tempts to commit suicide, among other data (e.g. DSM-IV
diagnoses) [4-6].
A genetic influence in SB is now widely acknowledged
and has received convincing support from familial, twin
and adoption studies [7,8], together with molecular genetic
studies mostly conducted on serotonergic candidate genes.
Moreover, the evidence from these various genetic studies
indicates that dysfunctions of the central serotonergic
system are involved in the pathogenesis of suicidal behav-
ior [9]. In this manner, of the several serotonin-related
genes studied in relation to SB, one of the most promising
is tryptophan hydroxylase (TPH) [10]. The principal rea-
son for testing the association between TPH genes and SBCentral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
González-Castro et al. BMC Psychiatry 2014, 14:196 Page 2 of 21
http://www.biomedcentral.com/1471-244X/14/196is that TPH is the first and rate-limiting step in the
synthesis of the serotonin neurotransmitter [11]. TPH
genes have been associated with low CSF 5-HIAA
levels in healthy volunteers and have been suggested as
a quantitative risk factor, in which a greater effect of
the gene results in the intensification of serotonergic
dysfunction associated with higher levels of anger and
more severe suicidal acts [12,13].
With regard to the TPH enzyme there are two genes
encoding it, both lie on intron seven: TPH-1, located on
the human chromosome 11p15.3-14, has an approximate
length of 29 kb and contains at least 11 exons and TPH-2
on chromosome 12q 21.1 covers a region of about 97 kb
and comprises also 11 exons [14]. Thus, variations in TPH
genes have prompted several researchers to conduct associ-
ation genetic studies on TPH single-nucleotide polymor-
phisms (SNPs) [15]. Of the several different polymorphisms
studied, most researches have focused on two SNPs in
TPH1 [16]. The first polymorphism, A779C (rs1799913),
was identified by single strand conformational analysis and
comes mainly in two alternative forms or alleles TPH 779A
and TPH 779C, referred to as U and L, respectively [17].
The second polymorphism, A218C (rs1800532), is in
complete or strong linkage disequilibrium with A779C in
various populations; both have been studied somewhat
interchangeably [9]. With regard to TPH2 gene variants,
the association with suicidal behavior is in progress and
until now several SNPs have been studied [10]. However,
the most common SNPS studied in connection with SB
are rs4570625 (G-703 T), rs11178997 (A-473 T) and
rs1386494 (G19918A) [18]. These SNPs have been
selected for their functional relevance. As a result, the
G-703 T polymorphism has been reported in higher
number in suicidal depressed patients compared with
healthy controls, whereas the A-473 T polymorphism
has raised large interest for its possible effect on gene
expression in the brainstem of depressed patients who
committed suicide [19]. Finally, the G19918A poly-
morphism has been found in association with completed
suicides [20].
Although there have been several positive studies associ-
ating TPH genes and SB the evidence is inconsistent. These
inconclusive results are probably due to small sample sizes,
different polymorphic markers used in the analysis, as well
as variations in sampling strategies, mainly in the control
groups, and the different ethnic populations assessed [21].
Although there are previous meta-analyses [18,22-25], we
decided to undertake another study in which in larger
number sample size and more rigorous selection criteria
could give us a better understanding into this matter. The
aims of the present study were to analyze the association of
TPH-1 (A218C and A779C) and TPH2 (G-703 T, A-473 T
and G19918A) genes with SB using a meta-analysis and
to integrate the outcomes of the several genetic studiesincluded in this methodology by taking into account
heterogeneity sources and the evaluation of possible bias
in publication. Given that several authors have shown that
the frequencies of TPH-1 and TPH-2 gene variants may
be ethnic-dependent, we decided to perform a sub-group
analysis by populations.
PICOT question
In population with suicidal behavior, what is the influence
of TPH-1 and TPH2 genes variants in manifesting a clinical
expression of suicidal behavior when compared to healthy
subjects?
Methods
The research protocol of this analysis is available upon
request. The meta-analysis and systematic review were
performed by following the Preferred Reporting Items
for Systematic Reviews and Meta-Analyses (PRISMA)
criteria [26,27].
Identification and selection of publications
Data were obtained by searching in EBSCO and PubMed
databases from May to Jun 2013. Relevant publications
were identified using the following search terms: “TPH1
and suicidal behavior” (PubMed: 23; EBSCO: 17), “TPH2 and
suicidal behavior” (PubMed: 28; EBSCO: 29), “TPH1 and
suicide” (PubMed: 25; EBSCO: 17), “TPH2 and suicide”
(PubMed: 46; EBSCO: 39), “Tryptophan hydroxylase and
suicidal behavior” (PubMed: 90; EBSCO: 53). These words
were combined to retrieve the summaries. The search also
implicated the review of the bibliography cited at the end of
the various research articles. To be selected, the publica-
tions had to meet the following criteria: (1) to be published
in peer-reviewed journals, (2) to contain independent data,
(3) to be case–control association studies in which the fre-
quencies of three genotypes were clearly stated or could
be calculated, (4) diagnosis of suicidal behavior of the pa-
tients in the study (suicide ideation, suicide attempt and
completed suicide), and (5) the use of healthy individuals
as controls. A final requirement was that the articles were
written in English. The following polymorphisms were
studied: A779C (rs1799913) and A218C (rs1800532) of
the TPH-1 gene, and rs4570625 (G-703 T), rs11178997
(A-473 T), and rs1386494 (G19918A) of the TPH-2 gene.
Two researchers (González-Castro and Juárez-Rojop)
working independently screened each of the titles, ab-
stracts, and full texts to determine inclusion. When the
researchers were in disagreement a third researcher
(Tovilla-Zárate) was consulted.
Data extraction
The same authors mentioned above carefully extracted
the information from all the included publications. They
worked in an independent manner and in accordance
Figure 1 Flow-chart showing the search strategy and inclusion/exclusion criteria used in the meta-analysis and systematic review.
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were obtained from each of the studies: authors, year of
publication, region, number of cases and controls, age,
gender, psychiatric diagnosis, number of males in the
groups and ethnical origin of the participants. These dataFigure 2 Distribution of association studies (cases-controls) on TPH gwere not always available for all the studies. In the cases of
missing data, we contacted the respective authors to ask
for the allele frequencies not included in the main text of
the papers. One of the studies did not include a control
group [28], but we made an adjustment accordingly basedenes variants and SB published in PubMed by year.
Table 1 Descriptive characteristics in association studies on A218C/A779C TPH-1 gene variants and SB by populations
Reference Location Diagnosis Number of males Number Genotypes Alleles P for HWE
Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls
AA/AC/CC AA/AC/CC A/C A/C
Caucasian population (A218C TPH-1 variant)
Bellivier F. et al., 1998 [62] France SA and manic-depression - 57 104 94 34/48/22 11/45/38 116/92 67/121 0.08 0.55
Geijer T. et al., 2000 [53] Sweden SA 57 64 165 98 30/87/48 13/47/38 147/183 73/123 1.00 0.43
Du L. et al., 2000 [54] Canada SC - - 35 84 6/24/5 13/52/19 36/34 78/90 0.04* 0.04*
Souery D. et al., 2001 [37] Germany, Greece, Israel,
Italy, Sweden, UK.
SI and bipolar disorder - - 167 167 29/85/53 27/74/66 143/191 128/206 0.41 0.75
Abbar M. et al., 2001 [47] France SA 105 170 231 281 43/120/68 30/133/118 206/256 193/369 0.50 0.30
Zalsman G.et al., 2001 [40] Israel SA 40 74 84 172 16/34/34 41/85/46 66/102 167/178 0.89 0.17
Turecki G. et al., 2001 [39] Canada SC - - 101 129 18/48/35 18/71/40 84/118 107/151 0.15 0.83
Rujescu D. et al., 2002 [36] Germany SA and anger related traits 27 66 86 154 10/48/28 19/78/57 68/104 116/192 0.39 0.17
Rujescu D. et al., 2003 [24] Germany SA 52 - 147 326 18/81/48 40/155/131 117/177 235/417 0.63 0.08
Jernej B. et al., 2004 [34] Croatia SC 144 298 185 358 84/85/16 202/141/15 253/117 545/171 0.14 0.49
Stefulj J. et al., 2005 [16] Croatia SC 160 284 160 284 21/69/70 44/145/95 111/209 233/335 0.39 0.60
Stefulj J. et al., 2006 [46] Croatia SC 247 320 247 320 33/111/103 50/162/108 177/317 262/378 0.48 0.78
Viana M.M. et al., 2006 [48] Brazil SA, major depression,
schizophrenia and
alcoholism
142 36 248 63 45/125/78 7/31/25 215/281 45/81 0.78 0.79
Baud P. et al., 2009 [28] Switzerland, France SA 166 - 537 1027 99/256/182 181/483/363 454/260 845/1209 0.59 0.34
Wilson T.et al., 2009 [52] USA SA and bipolar disorder - 39 71 101 13/44/14 22/43/36 70/72 87/115 0.22 0.05*
Saetre P. et al., 2010 [23] Denmark, Norway,
Sweden
SA and schizophrenia - 845 825 1460 289/391/145 570/694/196 969/681 1834/1086 0.00* 0.63
Buttenschon H.N. et al., 2013 [41] Denmark SC 209 763 490 1027 80/228/182 181/843/363 388/592 845/1209 0.36 0.57
868/1884/1131 1469/3282/1754 0.11 0.37
Asian population (A218C TPH-1 variant)
Tsai S.J. et al., 1999 [55] Taiwan SA and mood disorders - - 41 200 17/15/9 33/113/54 49/33 179/221 0.06 0.19
Liu X. et al., 2006 [56] China SA 171 98 287 177 72/148/67 41/84/49 292/282 166/182 0.65 0.63
Yoon H.K. et al., 2008 [44] Korea SA and major depression 70 73 193 191 49/97/45 60/85/48 195/187 205/181 0.11 0.88
Kunugi H. et al.,1999 [42] Japan SA - 95 46 208 10/29/7 55/105/48 49/43 215/201 1.00 0.13
Paik I. et al., 2000 [45] Korea SA and schizophrenia - 124 27 236 04/12/11 66/116/54 20/34 248/224 0.89 1.00
Ono H., et al., 2000 [43] Japan SC 90 90 132 132 29/68/35 26/71/35 126/138 123/141 0.38 0.86



















Table 1 Descriptive characteristics in association studies on A218C/A779C TPH-1 gene variants and SB by populations (Continued)
Ohtani M. et al., 2004 [49] Japan SC 95 171 134 325 30/60/42 44/113/57 120/144 201/227 0.41 0.37
253/486/257 367/822/419
Caucasian population (A779C TPH-1 variant)
Nielsen D.A. et al.,1998 [38] USA SI and alcoholism - 232 102 232 17/57/28 49/106/77 91/113 204/260 0.28 0.23
Rotondo A. et al., 1999 [51] Italy and USA SA - 153 97 153 12/50/35 33/68/52 74/120 215/201 0.25 0.51
Roy A. et al., 2001 [17] Sweden SC - - 24 158 02/12/20 35/86/37 16/332 156/160 0.33 1.00
Saetre P. et al., 2010 [23] Denmark, Norway and
Sweden
SA and schizophrenia - 845 830 1464 290/391/149 570/691/203 971/689 1831/1097 0.00* 0.63
Pooley E.C. et al., 2003 [50] UK SA 52 138 129 329 20/67/42 44/135/150 107/151 223/435 0.13 0.47
341/577/274 731/1086/519 0.44 0.34
Asian population (A779C TPH-1 variant)
Kunugi H. et al., 1999 [42] Japan SA - 95 46 208 10/29/7 55/105/48 49/43 215/201 1.00 0.13
Ohtani M. et al., 2004 [49] Japan SC 95 171 134 325 30/59/42 45/138/82 119/143 228/302 0.38 0.29
Liu X., et al. 2006 [56] China SA 171 98 266 164 77/126/63 43/85/36 280/252 171/157 0.75 0.46
117/214/112 143/328/166 0.50 0.47



















Table 2 Descriptive characteristics in association studies on G-703 T/A473T/G19918A TPH-2 gene variants and SB by populations
Reference Location Diagnosis Number of males Number Genotypes Alleles P for HWE
Cases Controls Cases Controls Cases Controls Cases Controls Cases Controls
GG/TG/TT GG/TG/TT T/G T/G
Caucasian population (G-703 T TPH-2 variant)
Zhou Z. et al., 2005 [61] USA SA and major depression 150 196 150 196 106/40/4 132/58/6 252/48 322/70 1.00 1.00
Zill P. et al., 2007 [60] Germany SA and alcoholism - 164 102 305 61/36/5 191/101/13 158/46 483/127 1.00 1.00
Stefulj J. et al., 2011 [57] Croatia SC 291 280 291 280 181/96/14 183/80/17 458/124 446/114 0.06 0.72
348/172/23 506/239/36 0.78 0.26
Asian population (G-703 T TPH-2 variant)
Mouri K. et al., 2009 [58] Japan SC 156 162 234 260 62/117/55 80/128/52 241/227 288/232 1.00 1.00
Yoon H.K. et al., 2008 [44] Korea SA and major depression 82 80 181 176 58/81/42 34/82/60 197/165 150/202 0.18 0.53
120/198/97 114/210/112 0.37 0.44
Reference Location Diagnosis Number of males Number Genotypes Alleles P for HWE
Cases Cases Cases Controls Cases Controls Cases Controls Cases Controls
AA/AT/TT AA/AT/TT A/T A/T
Caucasian population (A-473 T TPH-2 variant)
Zhou Z. et al., 2005 [61] USA SA and major depression 150 196 150 196 0/14/136 0/15/181 14/286 15/377 1.00 1.00
Zupanc T.et al., 2011 [19] Slovenia SC and alcoholism - - 383 222 0/42/341 2/31/189 42/724 35/409 0.61 0.63
0/56/177 2/46/370 0.36 0.65
Asian population (A-473 T TPH-2 variant)
Mouri K.et al., 2009 [58] Japan SC 156 162 234 260 2/44/188 3/48/209 48/420 54/466 1.00 0.74
Reference Location Diagnosis Number of males Number Genotypes Alleles P for HWE
Cases Cases Cases Controls Cases Controls Cases Controls Cases Controls
GG/GA/AA GG/GA/AA G/A G/A
Caucasian population ( G19918A TPH-2 variant)
Zill P. et al.,2004 [20] Germany SC 191 138 263 266 195/63/5 166/88/12 453/73 420/112 1.00 1.00
Zill P. et al.,2007 [60] Germany SA and alcoholism - 164 102 305 4/31/67 12/98/195 39/165 122/488 0.75 1.00
Must A. et al., 2009 [59] Estonia SC 298 327 288 327 206/75/7 242/79/6 487/89 563/91 1.00 1.00
Buttenschon H.N. et al.,2013 [41] Denmark SC 209 763 553 1033 396/150/7 743/268/22 942/169 1754/312 0.09 0.08
801/319/86 1163/533/235 0.06 0.09
Asian population ( G19918A TPH-2 variant)
K. Mouri et al.2009 [58] Japan SC 156 162 234 260 219/15/0 239/21/0 453/234 499/260 1.00 1.00



















Table 3 Meta-analysis of case–control studies on A218C/A779C TPH-1 gene variants in patients with suicidal behavior







Egger’s testRandom effects Fixed effects Random effects Fixed effects
OR (CI 95%) OR (CI 95%) OR (CI 95%) OR (CI 95%)
All populations
Allelic With heterogeneity 1.10 (0.98-1.22) 1.09 (1.04-1.16) <0.001 0.85 0.96 (0.76-1.22) 1.09 (0.99-1.21) <0.0001 0.46
Without heterogeneity 1.02 (0.94-1.11) 1.01 (0.95-1.08) 0.11 0.27 0.97 (0.85-1.11) 0.97 (0.85-1.11) 0.43 0.24
Additive With heterogeneity 1.22 (0.98-1.52) 1.22 (1.09-1.37) <0.00001 0.95 1.02 (0.67-1.54) 1.29 (1.04-1.59) 0.001 0.25
Without heterogeneity 1.06 (0.90-1.24) 1.04 (0.92-1.19) 0.15 0.50 0.92 (0.71-1.19) 0.92 (0.71-1.19) 0.42 0.11
Dominant With heterogeneity 1.16 (0.96-1.41) 1.16 (1.07-1.27) <0.0001 0.93 1.17 (0.75-1.83) 1.43 (1.21-1.69) <0.0001 0.07
Without heterogeneity 1.04 (0.91-1.18) 1.02 (0.93-1.13) 0.07 0.65 1.00 (0.82-1.22) 1.00 (0.82-1.22) 0.47 0.73
Recessive With heterogeneity 1.10 (0.94-1.28) 1.04 (0.95-1.15) 0.0005 0.15
Without heterogeneity 0.97 (0.87-1.08) 0.97 (0.87-1.08) 0.97 0.80 0.88 (0.72-1.08) 0.90 (0.76-1.06) 0.23 0.23
Caucasian population
Allelic With heterogeneity 1.12 (0.971.29) 1.10 (1.04-1.17) <0.0001 0.69 0.90(0.62-1.30) 1.11(0.98 1.25) <0.0001 0.60
Without heterogeneity 1.01(0.91-1.13) 1.00 (0.93-1.08) 0.006 0.36 0.95(0.78-1.14) 0.95(0.78 1.14) 0.58 0.25
Additive With heterogeneity 1.25 (0.95-1.64) 1.22 (1.07-1.39) <0.0001 0.73 0.89(0.46-1.71) 1.36 (1.05 1.75) <0.0001 0.80
Without heterogeneity 1.05(0.87-1.27) 1.03 (0.88-1.19) 0.18 0.22 0.80(0.55-1.16) 0.80(0.55-1.16) 0.69 0.94
Dominant With heterogeneity 1.24(0.96-1.59) 1.20 (1.09-1.32) <0.0001 0.68 1.17(0.75-1.83) 1.43(1.21-1.69) <0.0001 0.40
Without heterogeneity 1.12(0.97-1.28) 1.10 (0.97-1.25) 0.35 0.06 1.09(0.83-1.44) 1.09(0.83 -1.44) 0.77 0.58
Recessive With heterogeneity 1.02 (0.841.24) 0.97 (0.87-1.09) <0.0001 0.34 0.81(0.67-0.98) 0.81(0.670.98) <0.0001 0.30
Without heterogeneity 0.95 (0.84-1.06) 0.95 (0.84-1.06) 0.66 0.20 0.68(0.51-0.91) 68(0.51-0.91) 0.71 0.31
Asian population
Allelic With heterogeneity 1.06(0.89-1.27) 1.06 (0.94-1.20) 0.04 0.72 1.05(0.88 1.27) 1.05(0.88-1.27) 0.93 0.84
Without heterogeneity 1.11(0.95-1.28) 1.10 (0.97 1.24) 0.21 0.30
Additive With heterogeneity
Without heterogeneity 1.17(0.83-1.65) 1.18 (0.93 1.50) 0.06 0.69 1.15(0.79-1.68) 1.15(0.79-1.68) 0.83 0.76
Dominant With heterogeneity 0.99(0.73-1.35) 0.99(0.73-1.35) 0.45 0.10
Without heterogeneity 1.01(0.82-1.25) 1.01(0.84-1.23) 0.31 0.27 0.92(0.67.1.28) 0.92(0.67-1.28) 0.88 1.000
Recessive With heterogeneity 1.18(0.81-1.72) 1.19(0.97-1.45) 0.002 0.89 1.16(0.86-1.58) 1.16(0.86-1.58) 0.40 0.54
Without heterogeneity 0.94(0.74-1.18) 0.94 (0.74-1.18) 0.52 0.27
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http://www.biomedcentral.com/1471-244X/14/196on the other studies in the literature that included a control
group [29]. Briefly, we calculated the weighted frequency
for a particular genotype from studies that included
controls and applied it to the study without a controlFigure 3 Odds ratios and forest plots of A218C in overall studies with
B) Additive; C) Dominant, and D) Recessive.group. We considered the number of the “virtual” control
group equal to the number of patients in the specific study.
Then the hypothetical number of subjects with the particu-
lar genotype frequency was assigned in proportion to theout heterogeneity, using the following models: A) Allelic;
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http://www.biomedcentral.com/1471-244X/14/196percentage of the same genotype which was obtained from
the weighted analysis [30,31]. The outcomes of the meta-
analysis were built by taking into consideration the categor-
ies reported in previously published studies [32,33].
Figure 1 shows the stages of the meta-analysis. The
combined search included 367 potentially relevant articles.
Finally, 37 articles were obtained after discarding over-
lapping references that did not agree with the inclusion
criteria [16,17,19-24,28,34-61]; Figure 2 shows the articles
published at this stage of the analysis. In the case ofFigure 4 Egger’s funnel plots indicating publication bias in studies on
using the following models: A) Allelic; B) Additive; C) Dominant, andTPH-1 gene variants (A218C and A779C), 5683 cases
and 11652 controls were involved, whereas for the
TPH-2 gene variants (G-703 T, A-473 T and G19918A)
4196 cases and 5990 controls were considered (Tables 1
and 2, respectively).
Data analysis
For the meta-analysis procedures we used the EPIDAT 3.1
program (http://www.sergas.es/MostrarContidos_N3_T01.
aspx?IdPaxina=62715). This software is freely available forsuicidal behavior and the A218C variant without heterogeneity,
D) Recessive models.
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http://www.biomedcentral.com/1471-244X/14/196epidemiologic analysis of tabulated data. Data were ana-
lyzed with the random-effects and fixed effects models fol-
lowing the reports in the literature [63-65]. Sample
heterogeneity was analyzed with the Dersimonian and
Laird’s Q test. Q test results were complemented with
graphs to help the visualization of those studies favoring
heterogeneity. The studies outside the heterogeneity curve
were excluded. The results of the meta-analysis are
expressed as odds ratios (ORs). Pooled ORs were cal-
culated respectively for each of the models used, viz.:
allelic (Example: A vs. C), additive (AA vs. CC), dominant
(AA +AC vs. CC), and recessive (AA vs. AC +CC). Also,Figure 5 Odds ratios and forest plots of A779C in overall studies with
B) Additive; C) Dominant, and D) Recessive.we analyzed TPH1 and TPH2 gene variants by Caucasian
and Asian populations. To address the problem of pub-
lication bias, the Egger’s test and funnel plots were cal-
culated with the EPIDAT 3.1 software. This plotting
standardizes the effect of each of the published studies
on the vertical axis and its correspondent precision on
the horizontal axis. Also, we evaluated publication bias
using the GRADE approach and assessed the risk for
bias. Finally, a chi-squared (χ2) analysis was used to
calculate the Hardy-Weinberg equilibrium to evaluate
genotype distribution. Studies deemed for inclusion in
the systematic review were scored for methodologicalout heterogeneity, using the following models: A) Allelic;
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http://www.biomedcentral.com/1471-244X/14/196quality using the Newcastle-Ottawa Assessment Scale
(NOS). A score of six or more was taken as the cut-off
point to distinguish high from low quality studies [66]
(see Additional file 1).
Results
We measured the Hardy-Weinberg equilibrium (HWE)
in both groups (cases and controls) for all the samples
of TPH genes; we also explored all populations in a
combined way. Results are shown in Tables 1 and 2.Figure 6 Egger’s funnel plots indicating publications bias in studies o
using the following models: A) Allelic; B) Additive; C) Dominant, andTPH-1 gene variants
A218C polymorphism
Firstly, an analysis of the variant A218C (rs1800532) of
the TPH-1 gene was performed. In this study we evaluated
the role of this variant in several models: allelic, additive,
dominant and recessive. Also, we considered the Caucasian
and Asian populations separately, using the same four
models. And as in a previous meta-analysis [18,22-25], we
found a positive association of A218C variant with SB in
the fixed effects model, but not in the random effectsn suicidal behavior and the A779C variant without heterogeneity,
D) Recessive models.
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http://www.biomedcentral.com/1471-244X/14/196model. Our results are presented in Table 3. Figures 3 and
4 present the forest plots and Egger’s test of the same four
models previously mentioned (allelic, additive, dominant
and recessive).
A779C polymorphism
With this variant we conducted the same analyses than
in the previous variant gene (A218C). We observed a
significant association with suicidal behavior, using the fixed
effects model. This analysis was extended to Caucasian and
Asian populations treated separately. Table 3 shows in
more detail the analysis of this variant gene in all the
models tested (allelic, additive, recessive and dominant).




The first variant analyzed was the G-703 T (rs4570625)
polymorphism. Initially, we explored the association of the
G allele and patients with SB; we did not find significant
differences (Random effects: OR: 1.02; 95% CI 0.85-1.22;
p(Z) =0.99). We observed heterogeneity in all studies
(Q = 12.43; df = 6; p = 0.04). The Egger's test provided
no evidence of publication bias (t = 0.04; df = 5; p = 0.96)
(see Additional file 1). Next, we excluded the study by
Yoon and Kim [44], based on heterogeneity, and still weFigure 7 Odds ratios and forest plots of the G-703 T TPH-2 variant in
models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.could not find any significant differences (Random effects:
OR: 0.93; 95% CI 0.81-1.06; p(Z) =0.70; Figure 7A; Q test =
1.73; df = 5; p = 0.88). Also, there was no evidence of publi-
cation bias (Egger’s test: t = 1.01, df = 4; p = 0.36; Figure 8A).
The same results were found when we used the additive
model without heterogeneity (Random effects: OR: 0.88;
95% CI 0.65-1.20; p(Z) =0.45; Figure 7B; Q test = 1.65;
df = 6; p = 0.89). No evidence of publication bias was en-
countered (Egger’s test t = 1.03; df = 5; p = 0.36; Figure 8B).
We did not find any significant differences when we used
the dominant model without heterogeneity either (Random
effects: OR: 1.07; 95% CI 0.84-1.38; p(Z) =0.76; Figure 7C; Q
test = 6.43; df = 6; p = 0.37). Similarly, no evidence of publi-
cation bias was observed (Egger’s test: t = 0.24, df = 5; p =
0.83; Figure 8). Finally, the same negative results were found
in the recessive model without heterogeneity (Random ef-
fects: OR: 0.91; 95% CI 0.76-1.09; p(Z) =0.45; Q test = 1.76;
df = 6; p = 0.88; Figure 7D). No evidence of publication bias
was encountered (Egger’s test: t = 0.46; df = 5; p = 0.66;
Figure 8D). In addition, we conducted the same analyses
using the allelic, additive, dominant and recessive models
in Asian and Caucasian populations, separately. However,
we could not find any significant differences (Table 4).
A473T polymorphism
Also, we conducted an analysis of allele A of the A-473 T
(rs11178997) polymorphism in association with SB andoverall studies without heterogeneity, using the following
Figure 8 Egger's funnel plots indicating publication bias in studies on suicidal behavior and the G-703 T TPH-2 variant without
heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.
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(Random effects: OR: 0.89; 95% CI 0.63-1.26; p(Z) =0.98;
Q test = 18.81 df = 5; p = 0.002). No evidence of publica-
tion bias was found (Egger’s test t = 0.83, df = 4; p = 0.44).
Next, we eliminated heterogeneity by excluding the study
by Zhou et al. [61] in a Caucasian population (Random
effects: OR:0.76; 95% CI 0.61-0.95; p(Z) =0.80; Q test =
4.54; df = 4; p = 0.33; Figure 9A) and found no significant
differences. Besides, we did not encounter evidence ofpublication bias (Egger’s test: t = 1.04; df = 3; p = 0.37;
Figure 10A). When we used the additive model, we ex-
cluded the studies by Zupanc et al. [19] and Zhou et al.
[61] in the Caucasian population given that some frequen-
cies were equal to zero. Still, we did not find any significant
differences without heterogeneity (Random effects: OR:
1.00; 95% CI 0.52-1.93; p(Z) =0.73; Figure 9B; Q test = 2.91;
df = 3; p = 0.40); also we did not encounter evidence of
publication bias (Egger’s test: t = 0.36, df = 2; p = 0.74;
Table 4 Meta-analysis of case–control studies on G-703 T/ A-473 T/G19918A TPH-2 gene variants and SB by populations
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Figure 9 Odds ratios and forest plots of the A-473 T TPH-2 variant in overall studies without heterogeneity using the following
models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.
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http://www.biomedcentral.com/1471-244X/14/196Figure 10B). A negative result was also found for the
dominant model without heterogeneity (Random ef-
fects: OR: 1.01; 95% CI 0.76-1.34; p(Z) =0.70; Figure 9C;
Q test = 10.46; df = 5; p = 0.06); no evidence of publica-
tion bias was encountered (Egger’s test: t = 1.74; df = 4;
p = 0.15; Figure 10C). The same negative results were
obtained with the recessive model without heterogeneity
excluding the studies by Zupanc et al. [19] and Zhou et al.
[61] in the Caucasian population because some fre-
quencies were equal to zero (Random effects: OR:1.01;
95% CI 0.53-1.93; p(Z) =0.73; Figure 9D; Q test = 2.33;
df = 3; p = 0.50); there was no evidence of publication
bias (Egger’s test: t = 0.31; df = 2; p = 0.78; Figure 10D).
In addition, with regard to the analysis of the A-473 T
variant of the TPH-2 gene in relation to SB, we con-
ducted an analysis in the Caucasian population, using
the same four models as above and could not find any
significant differences (Table 4).
G19918A polymorphism
Finally, the G19918A (rs1386494) polymorphism was
the last variant studied in association with SB. When we
analyzed allele G vs allele A, we could not find any sig-
nificant differences in the analysis without heterogeneity
(Random effects: OR: 1.09; 95% CI 0.91-1.31; p(Z) =0.98;
Figure 11A; Q test = 10.32; df = 5; p = 0.06); we found no
evidence of publication bias (Egger’s test: t = 0.78; df = 4;
p = 0.47; Figure 12A). Subsequently, we performed an
analysis with the additive model without heterogeneity(Random effects: OR: 1.45; 95% CI 0.87-2.40; p(Z) =0.80;
Figure 11B; Q test = 3.70; df = 4; p = 0.44); we found no
evidence of publication bias (Egger’s test: t = 0.09; df = 3;
p = 0.95, Figure 12B). The same negative outcome was
found when using the dominant model without hetero-
geneity (Random effects: OR: 1.18; 95% CI 0.79-1.76; p
(Z) =0.80; Figure 11C; Q test = 4.38; df = 4; p = 0.35); no
evidence of publication bias was found (Egger’s test: t =
1.14; df = 3; p = 0.33; Figure 12C). The same result was
obtained with the recessive model without heterogeneity
(Random effects: OR: 1.16; 95% CI 0.90-1.50; p(Z) =0.45;
Figure 11D; Q test = 9.12; df = 5; p = 0.10); no evidence
of publication bias was encountered (Egger’s test: t = 0.74;
df = 4; p = 0.49; Figure 12D). Finally, we conducted an
analysis in the Caucasian population separately using
the same four models as in the other polymorphism,
and could not find any significant differences (Table 4).
Discussion
In this study, we explored the association of THP-1 and
TPH-2 gene polymorphisms with suicidal behavioral. We
found an association between A218C/ATT9C polymorph-
ism of TPH1 and suicidal behavior. However, we could
not find an association between TPH2 gene variants and
this behavior. To our knowledge, this is the first study
evaluating TPH2 gene variants and suicidal behavior.
Suicide has become a serious problem around the
world. Various published studies show the search for
possible genetic markers that could help in the early
Figure 10 Egger's funnel plots indicating publication bias in studies on suicidal behavior and the A-473 T TPH-2 variant without
heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.
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One possible mechanism by which genetic factors may
affect the risk for suicide is through the control of seroto-
nergic neurotransmission. TPH genes have been proposed
as the main candidate genes in association studies on
suicidal behavior, given that the TPH enzyme is a rate-
limiting step in serotonin biosynthesis. Despite the in-
creasing amount of genetic association studies on SB,the results are inconclusive. Therefore, we performed a
meta-analysis in order to evaluate the association of
TPH-1 and TPH-2 genes with SB in which we integrated
the outcomes of the different polymorphic markers and
different ethnic groups. Initially, although variants A218C
(rs1800532) and A779C (rs1799913) of the TPH-1 gene
have been studied in relation to suicidal behavior in differ-
ent meta-analyses [18,22-25], we analyzed the TPH-1 gene
Figure 11 Odds ratios and forest plots of the G19918A TPH-2 variant in overall studies without heterogeneity, using the following
models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.
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were A779C (rs1799913) and A218C (rs1800532); these
two polymorphisms are the most studied of the TPH-1
gene and with interesting outcomes. We not only analyzed
allele A vs allele C, but also evaluated the association using
three other models: additive, dominant and recessive in a
pool population that combined the genetic studies of
TPH-1 variants. In addition, we performed a sub-group
analysis in Caucasian and Asian populations separately to
evaluate the association of A779C (rs1799913) and A218C
(rs1800532) polymorphisms with SB using the same four
models. Our results are in agreement with previous meta-
analyses [18,22-25]. These studies report a strong associ-
ation with SB using the fixed effects model. In the present
meta-analysis we also found an association when we used
the fixed effects model, but not with the random effects
model. However, this result should be taken with caution
because the random effects model is more conservative
than the fixed effects one. The latter assumes the same
true genetic effects, and the former supposes normally dis-
tributed effects and parametrizes inter-studies variations.
To get a clearer panorama of the possible role of these
variants in SB, we summarized the results of our analyses
in Tables 3 and 4. The evidence suggests that TPH-1
A218C/A779C polymorphisms may be associated with
increased susceptibility to present SB clinically.
On the other hand, to explore the association of SB with
TPH-2 gene, we chose rs4570625 (G-703 T), rs11178997
(A-473 T) and rs1386494 (G19918A) variants, given their
functionality and the extensive amount of studies evalu-
ating these polymorphisms in association with SB. Weperformed the analysis with the same four models used
for the TPH1-gene: allelic, additive, dominant, and re-
cessive. We also conducted a sub-group analysis in the
Caucasian and Asian populations utilizing the same previ-
ously mentioned models. In the present study we could
not find any association in any of the models, but we
found a slight protective effect concerning polymorphism
A-473 T toward suicidal behavior in the recessive model
(Random effects: OR: 0.76; 95% CI 0.61-0.95; p(Z) =0.80;
Q test = 4.54; df = 4; p = 0.33); no evidence of publication
bias was encountered (Egger’s test: t = 1.04; df = 3; p = 0.37).
There are several explanations for the present outcomes
concerning the lack of association of TPH-2 variants with
SB. First, the criteria used in the selection of the control
groups differ among studies. Second, although the sub-
jects were patients with SB, there were differences in
the diagnoses (attempted, ideation and completed sui-
cide, and exclusion criteria of neuropsychiatric diseases,
among other factors). For example, Souery et al. [37]
work with patients with bipolar disorder that present
SB, Yoon and Kim [44] with depressive subjects and SB,
Paik et al. [45] with schizophrenic patients, and Turecki
et al. [39] with suicide completers only. Other possibility
is genetic heterogeneity: some authors have shown that
the distribution of the frequencies of TPH-2 variants
may depend on ethnicity. Therefore, we evaluated the
association of TPH2 variants with SB in several popula-
tions. The fourth explanation considers the presence of
other genes which may interact with TPH-2 to increase
the risk to present SB clinically. We also want to
emphasize the relevance of employing larger sample
Figure 12 Egger's funnel plots indicating publication bias in studies on suicidal behavior and the G19918A TPH-2 variant without
heterogeneity, using the following models: A) Allelic; B) Additive; C) Dominant, and D) Recessive.
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results.
This study has some limitations. First, we performed
the present meta-analysis based only on published studies.
We considered that by selecting only published results, we
ensured that our meta-analysis excluded poorly designed
studies. Second, although the present analysis involves a
large number of studies and genetic variants, it is relatively
small in comparison with other meta-analysis on differentdiseases. Also, we could not perform an analysis including
suicide ideation, suicide attempt, or completed suicide.
Other limitation is that we did not stratify the analysis by
gender because it was not always possible to obtain all the
data from the reports or directly from the authors. Also,
we did not perform the analysis of all the variants of the
TPH-2 gene in the Asian population because there were
not enough studies. Sixth, we did not evaluate SB endo-
phenotypes or psychopathologies which could increase
González-Castro et al. BMC Psychiatry 2014, 14:196 Page 19 of 21
http://www.biomedcentral.com/1471-244X/14/196the risk for suicidal behavior. One last comment: is that
although there are previous meta-analyses evaluating the
association of the TPH-1 gene (A218C and A779C vari-
ants) and SB, our study contains more recent data and the
use of various types of models to perform the analysis.
Conclusion
In summary, we performed a meta-analysis to assess the
association of A779C (rs1799913) and A218C (rs1800532)
variants of the TPH-1 gene, and rs4570625 (G-703 T),
rs11178997 (A-473 T), and rs1386494 (G19918A) of the
TPH-2 gene with SB. Our analysis of TPH-1 provided
evidence that A218C/A779C TPH-1 variants may be risk
factors to present SB, which is in agreement with previ-
ously reported meta-analyses [18,22-25]. With regard to
G-703 T/A-473 T/G19918A TPH-2 variants, our updated
meta-analysis did not detect any significant association
with patients presenting SB. However, these results should
be interpreted with caution because not all the models
detected this association and the sample size may be just
enough to detect small effects of the polymorphisms. Fur-
ther studies with larger samples in different ethnic popula-
tions need to be undertaken to confirm our findings.
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